This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bruzek, R. J. Articles by Dullinger, D. Search for Related Content Social Bookmarking                         What's this?

Drug Formulary: The Cornerstone of a Managed Pharmacy Program

Blue Cross and Blue Shield of Minnesota (Route 1-14), 3535 Blue Cross Rd, PO Box 64560, St Paul, MN 55164

Debra Dullinger

From Blue Cross and Blue Shield of Minnesota, St Paul, MN.

Drug formularies have migrated from the inpatient hospital environment to the ambulatory outpatient setting. Although formularies in use by managed health care organizations may vary widely in their design, they have quickly become the cornerstone of the managed pharmacy benefit. A carefully designed formulary can direct drug use to the safest and most efficacious products that may ultimately lower total drug costs. Other managed health care drug formulary considerations are presented. A method is described to develop a drug formulary. The drug evaluation matrix (DEM) provides a systematic, reproducible drug selection process based on efficacy, safety, and cost. DEM allows the user to assign different weights to these factors during the drug evaluation process. The product of DEM is a drug formulary that is therapeutically complete, consistent with accepted medical practice and maximizes cost efficiencies achievable from a drug formulary.

Journal of Pharmacy Practice, Vol. 5, No. 2, 75-81 (1992)
DOI: 10.1177/089719009200500206


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?